Stay updated on Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Recruitment status shows no longer looking for participants. New user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added, the Intervention/Treatment header formatting updated (from 'Intervention / Treatment' to 'Intervention/Treatment'), and the revision tag updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T06:00:38.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a small software update to the site.
    Difference
    0.1%
    Check dated 2026-06-08T03:48:48.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page no longer displays links or sections for bladder cancer, related topics, and MedlinePlus Genetics, reducing navigational references to these topics on the study page.
    Difference
    0.2%
    Check dated 2026-06-01T01:07:38.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    New navigation items were added to the page: 'Bladder cancer' and a 'related topics' section featuring 'MedlinePlus Genetics', providing additional context and links to related resources.
    Difference
    0.2%
    Check dated 2026-05-24T13:24:30.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Revision note updated to v3.5.4, replacing v3.5.3 and signaling a minor update to the page's documentation.
    Difference
    0.1%
    Check dated 2026-05-17T08:42:10.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Removal of items in the Related topics section, specifically Bladder cancer and MedlinePlus Genetics. This alters the navigation and topic tagging on the page, while the core study information remains unchanged.
    Difference
    0.2%
    Check dated 2026-05-10T09:20:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.